Edmond de Rothschild Holding’s AstraZeneca AZN Stock Holding History

Edmond de Rothschild Holding’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$76.8M	Buy	411,773 +10,220	+3%	+$1.92M	1.01%	23
2026 Q1	$78.1M	Buy	+401,553	New	+$77.4M	1.13%	20
2024 Q1	–	Sell	-26,229	Closed	-$3.53M	–	680
2023 Q4	$3.53M	Buy	26,229 +3,845	+17%	+$500K	0.06%	188
2023 Q3	$3.03M	Buy	22,384 +1,021	+5%	+$139K	0.06%	196
2023 Q2	$3.06M	Buy	21,363 +2,632	+14%	+$387K	0.06%	216
2023 Q1	$2.6M	Buy	18,731 +1,172	+7%	+$158K	0.06%	219
2022 Q4	$2.38M	Buy	17,559 +1,087	+7%	+$136K	0.06%	225
2022 Q3	$1.81M	Sell	16,472 -2,142	-12%	-$272K	0.05%	249
2022 Q2	$2.46M	Buy	18,614 +4,744	+34%	+$622K	0.06%	231
2022 Q1	$1.84M	Buy	+13,870	New	+$1.66M	0.04%	271

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Edmond de Rothschild Holding's AZN Position: Q2 2026 in Review

Edmond de Rothschild Holding increased its AstraZeneca (AZN) stake by 2.5% in Q2 2026, buying an estimated $1.92M and bringing the position to 411,773 shares worth $76.8M. The position accounts for 1.01% of the portfolio, ranked #23.

Edmond de Rothschild Holding first reported a position in AZN in Q1 2022 and has held it in 10 quarters since. The position peaked at $78.1M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Edmond de Rothschild Holding held 411,773 shares of AstraZeneca worth $76.8M as of Q2 2026.
Edmond de Rothschild Holding bought 10,220 AstraZeneca shares in Q2 2026, an estimated $1.92M.
AstraZeneca made up 1.01% of Edmond de Rothschild Holding's portfolio in Q2 2026, its #23 holding.
Edmond de Rothschild Holding first reported a position in AstraZeneca in Q1 2022 and has held it in 10 quarters since.
Edmond de Rothschild Holding's AstraZeneca position peaked at $78.1M in Q1 2026.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2026, filed 10 Aug 2026.